Cargando…
BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients
Background: The emergence of new SARS-CoV-2 variants, which evade immunity, has raised the urgent need for multiple vaccine booster doses for vulnerable populations. In this study, we aimed to estimate the BNT162b2 booster effectiveness against the spread of coronavirus variants in a hemodialysis po...
Autores principales: | Herman-Edelstein, Michal, Ben-Dor, Naomi, Agur, Timna, Guetta, Tali, Raiter, Annat, Meisel, Eshcar, Alkeesh, Weaam, Ori, Yaacov, Rozen-Zvi, Benaya, Zingerman, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227334/ https://www.ncbi.nlm.nih.gov/pubmed/35746575 http://dx.doi.org/10.3390/vaccines10060967 |
Ejemplares similares
-
Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients
por: Agur, Timna, et al.
Publicado: (2022) -
SARS-CoV-2 antibody dynamics among kidney transplant recipients 3 months after BNT162b2 vaccination: a prospective cohort study
por: Yelin, Dana, et al.
Publicado: (2022) -
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study
por: Yahav, Dafna, et al.
Publicado: (2022) -
The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
por: Jacobson-Naftali, Merav, et al.
Publicado: (2023) -
Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial
por: Zingerman, Boris, et al.
Publicado: (2015)